Q4 2025 Management View CEO Andrew Toy stated the company achieved "full year adjusted EBITDA profitability, delivered a well-controlled medical cost trend and reestablished market-leading membership ...
Achieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retention Expect improving cohort economics powered by Clover Assistant to drive our first-ever full year ...
In 2025, both new and returning member cohort contribution profit performed in line with expectations. Returning member ...
Clover Health Investments, Corp. (NASDAQ:CLOV) is one of Goldman Sachs’ top penny stock picks. On January 29, 2026, Clover ...
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong ...
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, ...
Fourth Quarter and Full Year 2025 Conference Webcast Details: A live and archived webcast of the conference call will also be accessible from the Investor Relations section of Clover Health’s website ...
It has been about a month since the last earnings report for Clover Health Investments, Corp. (CLOV). Shares have lost about 11.6% in that time frame, underperforming the S&P 500. Will the recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results